XML 23 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities:    
Net income (loss) $ 4,562,389 $ (8,539,699)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Unrealized (gain) loss on open futures contracts 1,175,940 (1,666,380)
(Increase) decrease in receivable from General Partner (59,168) (120,259)
(Increase) decrease in dividends receivable (10,933) (2,035)
(Increase) decrease in interest receivable 2,788 0
(Increase) decrease in directors' fees and insurance receivable 0 (3,196)
Increase (decrease) in payable due to Broker 0 1,936,460
Increase (decrease) in General Partner management fees payable (9,238) (9,687)
Increase (decrease) in professional fees payable (1,247) 33,054
Increase (decrease) in brokerage commissions payable (2,500) (1,860)
Increase (decrease) in directors' fees and insurance payable 1,179 (1,184)
Net cash provided by (used in) operating activities 5,659,210 (8,374,786)
Cash Flows from Financing Activities:    
Addition of partnership shares 3,704,236 764,363
Redemption of partnership shares (12,686,394) (3,091,601)
Net cash provided by (used in) financing activities (8,982,158) (2,327,238)
Net Increase (Decrease) in Cash and Cash Equivalents (3,322,948) (10,702,024)
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 92,511,503 111,464,877
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 89,188,555 100,762,853
Components of Cash and Cash Equivalents:    
Cash and Cash Equivalents 78,109,650 92,769,457
Equity in Trading Accounts:    
Cash and Cash Equivalents 11,078,905 7,993,396
Total Cash, Cash Equivalents and Equity in Trading Accounts $ 89,188,555 $ 100,762,853